Nathan Gross
On June 10, 2025, Dr. Nathan Gross notified Doximity, Inc. (the “Company”) that he will step down from his role as Chief Strategy Officer to become an advisor to the Company, effective June 16, 2025.
Highest-materiality recent filing
Doximity Q4 GAAP net income sinks 69%; guides ~4% FY2027 revenue growth; new CFO and President
FY2026 revenue $644.9M (+13% YoY); GAAP net income $196.1M (down 12% YoY, margin 30.4%).
Doximity CFO Anna Bryson resigns; interim CFO continues; guidance reaffirmed
Anna Bryson's resignation as CFO accepted April 13, 2026, following medical leave since Feb 5, 2026.
Doximity Q3 revenue up 10% to $185M, guides Q4 $143-144M, authorizes $500M buyback
Revenue $185.1M (+10% YoY); net income $61.6M (33% margin) vs $75.2M (45% margin) YoY.
Doximity reports Q2 revenue $168.5M (+23% YoY), adjusted EBITDA $100.8M; raises FY guidance
Revenue $168.5M vs $136.8M YoY, up 23%; non-GAAP net income $90.0M (53.4% margin).
Doximity Q1 revenue $145.9M (+15%), adj. EBITDA $79.8M (+21%), raises FY guidance
Revenue $145.9M (+15% YoY); net income $53.3M (36.5% margin); non-GAAP EPS $0.36.
On June 10, 2025, Dr. Nathan Gross notified Doximity, Inc. (the “Company”) that he will step down from his role as Chief Strategy Officer to become an advisor to the Company, effective June 16, 2025.
Max materiality 0.85 · Median 0.65 · Most common event earnings